Publication Name	World Journal of Clinical Oncology
Manuscript ID	33202
Country	United States

Received	2017-02-07 19:11
Peer-Review Started	2017-02-12 23:15
To Make the First Decision	2017-03-08 09:41
Return for Revision	2017-03-10 17:14
Revised	2017-03-25 11:10
Second Decision	2017-04-18 13:56
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2017-04-24 10:51
Articles in Press	2017-04-24 10:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-05-26 04:53
Publish the Manuscript Online	2017-06-02 05:29

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Prostatic adenocarcinoma oncocytic variant: Case report and literature review
Manuscript Source	Invited Manuscript
All Author List	Matthew M Klairmont and Nadeem Zafar
Funding Agency and Grant Number
Corresponding Author	Nadeem Zafar, MD, Associate Professor, Department of Pathology, University of Tennessee Health Science Center, 930 Madison 5th Floor, Memphis, TN 38163, United States. nzafar@uthsc.edu
Key Words	Prostate; Adenocarcinoma; Clinical behavior; Oncocytic; Gleason; Prognosis
Core Tip	The oncocytic variant of prostatic adenocarcinoma is exceptionally rare with only 4 cases reported so far. Through reporting this new case, the oncocytic variant is being highlighted and challenges associated with its accurate diagnosis and staging discussed. The use of immunohistochemistry to confirm prostatic origin of this tumor for accurate grading of this lesion is also highlighted. It is also postulated that the tumor cells may be difficult to locate for their presence and organization at hematoxylin and eosin evaluation, potentially resulting in inaccurate grading of the tumor, the tumor likely behaves no different from the usual/typical variant of acinar-type adenocarcinoma if appropriately graded.
Publish Date	2017-06-02 05:29
Citation	Klairmont MM, Zafar N. Prostatic adenocarcinoma, oncocytic variant: Case report and literature review. World J Clin Oncol 2017; 8(3): 289-292
URL	http://www.wjgnet.com/2218-4333/full/v8/i3/289.htm
DOI	http://dx.doi.org/10.5306/wjco.v8.i3.289

Full Article (PDF)	WJCO-8-289.pdf
Full Article (Word)	WJCO-8-289.doc
Manuscript File	33202-Review.docx
Answering Reviewers	33202-Answering reviewers.pdf
Audio Core Tip	33202-Audio core tip.wav
Conflict-of-Interest Disclosure Form	33202-Conflict-of-interest statement.pdf
Copyright License Agreement	33202-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	33202-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	33202-Institutional review board statement.pdf
Peer-review Report	33202-Peer-review(s).pdf
Scientific Misconduct Check	33202-Scientific misconduct check.pdf
Scientific Editor Work List	33202-Scientific editor work list.pdf